Technology | February 20, 2014

ACR BI-RADS Breast Density Categories Change

Volpara Solutions applauds emphasis on volumetric assessment of breast density

ACR BI-RADS Breast Density VolparaDensity Mammography Women's Healthcare

February 20, 2014 — The fifth edition of Breast Imaging-Reporting and Data System (BI-RADS) Atlas issued by the American College of Radiology (ACR) included changes in breast density reporting categories. Volpara Solutions, producers of VolparaDensity software, said this is a step toward the provision of accurate breast density measurements to women by the renewed emphasis on volumetric assessments. 

“We commend the ACR for proactively working to improve breast density assessment, which is critical to the identification of women who may benefit from supplemental imaging to improve the early detection of cancer,” said Ralph Highnam, Ph.D., CEO of Volpara Solutions. “First, through the repeated assertion that breast composition measurement is about the volume of attenuating tissue in the breast, and second, by removing the old area-based percentage thresholds which have been proven to be subjective and imprecise. Not only does this help clarify what breast density assessment should be, but the fifth edition also helps distinguish density from other BI-RADs assessments.”

The new breast composition categories are: 

  • The breasts are almost entirely fatty
  • There are scattered areas of fibroglandular density
  • The breasts are heterogeneously dense, which may obscure small masses
  • The breasts are extremely dense, which lowers the sensitivity of mammography

 

Volpara software generates an objective, automatic measurement of volumetric breast density and a U.S. Food and Drug Administration (FDA) cleared BI-RADS breast density category. The technology is cleared by the FDA, HealthCanada, the TGA and has CE marking. Volpara supports most of the major digital mammography systems, can be displayed on digital mammography and PACS workstations and be integrated into mammography reporting systems.

For more information: volparasolutions.com

Related Content

Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
The Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. The FDA granted approval of the Sentimag System to Endomagnetics Inc.

The  Endomagnetics' Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

Technology | Women's Health | July 24, 2018
July 24, 2018 — The U.S.
Overlay Init